Aims: To ascertain the effectiveness of medical therapy for reducing risk in peripheral artery
disease (PAD) and to model the potential impact of combining multiple efficacious …

Peripheral arterial disease (PAD) is underdiagnosed and undertreated. This is despite the
high vascular morbidity and mortality rates associated with PAD. There is also evidence that …

BACKGROUND: Patients with peripheral arterial disease (PAD) have increased mortality
compared with patients without PAD. Coronary artery disease (CAD) accounts for almost …

Background Patients with peripheral artery disease (PAD) have a higher risk of major
adverse cardiovascular events (MACE) compared with those without PAD. Objectives The …

Lipid Lowering Therapy in the Treatment of Lower Limb Atherosclerosis Page 1 Eur J Vasc
Endovasc Surg 16, 5-6 (1998) COCHRANE REVIEW Lipid Lowering Therapy in the Treatment of …

Peripheral arterial disease (PAD) is a prevalent medical condition associated with high
mortality and morbidity rates. Despite the high clinical burden, sex-based differences among …

Aims Due to a high burden of systemic cardiovascular events, current guidelines
recommend the use of statins in all patients with peripheral artery disease (PAD). We sought …

In 1986 Michael Brown and Joseph L. Goldstein were awarded the Nobel Prize in Medicine
for their seminal discovery of the LDL-receptor [1, 2]. In their Nobel Prize Lecture in …

Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …

Peripheral artery disease (PAD) commonly refers to atherosclerotic narrowing of
noncoronary arteries, primarily those supplying the lower extremities. The risk factors for …